Brokerage firm Prabhudas Lilladher has initiated a 'Buy' rating on ICICI Prudential Life Insurance, setting a target price of Rs 725. With the stock currently trading near Rs 460, the report highlights a 25% year-on-year rise in quarterly profit and steady growth in protection and annuity products, despite challenges in the ULIP segment.
Brokerage firm Prabhudas Lilladher has initiated coverage on ICICI Prudential Life Insurance with a 'Buy' rating and a target price of Rs 725. This development comes as the insurer's stock trades around the Rs 460 to Rs 463 level as of mid-October 2026. The analyst view reflects confidence in the company's business strategy, despite broader market volatility that has impacted the insurance sector recently.
Financial Performance and Growth
The company’s recent Q2 FY27 results showed resilient performance, with a standalone net profit of Rs 374 crore, marking a 25% increase compared to the same period last year. Business growth, measured by Annual Premium Equivalent (APE), rose by 15.5% to reach Rs 2,799 crore. This momentum was primarily supported by strong demand in the annuity and protection segments. While these areas performed well, the company continues to navigate challenges in the Unit Linked Insurance Plans (ULIP) segment, where market fluctuations have dampened investor appetite.
Profitability and Business Mix
Profitability metrics remain a key focus for investors. The Value of New Business (VNB) margin for the quarter stood at 25.4%, showing an improvement over the previous year. The company is actively shifting its product mix to focus on higher-margin offerings, with Non-Par products now accounting for 40% of the total mix. This strategic pivot is intended to defend and expand margins in a competitive environment. Furthermore, the company maintains a strong solvency ratio of 229.9%, which indicates a stable capital position to support future business operations.
Market Risks and Monitorables
While the brokerage remains positive, the report acknowledges several risks that could influence future performance. One significant monitorable is the potential impact of regulatory changes, specifically concerning commission consultation papers, which could alter the industry landscape. Additionally, the company faces a 'high-base effect' in the second half of the 2027 fiscal year, as it compares its current performance against a very strong period from the second half of fiscal year 2026. Investors may also track whether the current product mix shift can sustain margin levels if market conditions remain volatile or if competitive pressure intensifies in the protection segment.